Baylor College of Medicine: Study Looks at Role of Hematopoietic Stem and Progenitor Cells in Treating Sepsis
February 16, 2022
February 16, 2022
HOUSTON, Texas, Feb. 16 (TNSJou) -- The Baylor College of Medicine issued the following news on Feb. 15, 2022:
Sepsis, an inflammatory syndrome that occurs when the body has an extreme response to an infection, is responsible for about 20% of deaths worldwide. A new study by researchers at Baylor College of Medicine suggests that infusion of new, healthy hematopoietic stem and progenitor cells (HSPCs) from the bone marrow could improve sepsis outcomes in a mouse model, with the hope . . .
Sepsis, an inflammatory syndrome that occurs when the body has an extreme response to an infection, is responsible for about 20% of deaths worldwide. A new study by researchers at Baylor College of Medicine suggests that infusion of new, healthy hematopoietic stem and progenitor cells (HSPCs) from the bone marrow could improve sepsis outcomes in a mouse model, with the hope . . .